Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue Academic Article uri icon

Overview

MeSH Major

  • Brain-Derived Neurotrophic Factor
  • Endothelial Cells
  • Endothelium, Vascular
  • Liver
  • Myocytes, Cardiac
  • Stem Cells
  • Vascular Endothelial Growth Factor A

abstract

  • CD133 defines a population of human fetal liver cells capable of differentiating into both angiogenic and myogenic cells. Preconditioning of these CD133+ cells with VEGF165 and BDNF enhances the angiomyogenesis. CD133+ fetal liver cells ultimately may be used for therapeutic angiomyogenesis.

publication date

  • March 8, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000157155.44008.0F

PubMed ID

  • 15753226

Additional Document Info

start page

  • 1175

end page

  • 83

volume

  • 111

number

  • 9